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Abstract
Pericytes are skeletal muscle resident, multipotent stem cells that are localized
to the microvasculature. In vivo, studies have shown that they respond to
damage through activation of nuclear-factor kappa-B (NF-jB), but the down-
stream effects of NF-jB activation on endothelial cell proliferation and cell–
cell signaling during repair remain unknown. The purpose of this study was
to examine pericyte NF-jB activation in a model of skeletal muscle damage;
and use genetic manipulation to study the effects of changes in pericyte
NF-jB activation on endothelial cell proliferation and cytokine secretion. We
utilized scratch injury to C2C12 cells in coculture with human primary peri-
cytes to assess NF-jB activation and monocyte chemoattractant protein-1
(MCP-1) secretion from pericytes and C2C12 cells. We also cocultured endo-
thelial cells with pericytes that expressed genetically altered NF-jB activation
levels, and then quantified endothelial cell proliferation and screened the con-
ditioned media for secreted cytokines. Pericytes trended toward greater NF-jB
activation in injured compared to control cocultures (P = 0.085) and in com-
parison to C2C12 cells (P = 0.079). Second, increased NF-jB activation in
pericytes enhanced the proliferation of cocultured endothelial cells (1.3-fold,
P = 0.002). Finally, we identified inflammatory signaling molecules, including
MCP-1 and interleukin 8 (IL-8) that may mediate the crosstalk between peri-
cytes and endothelial cells. The results of this study show that pericyte NF-jB
activation may be an important mechanism in skeletal muscle repair with
implications for the development of therapies for musculoskeletal and vascular
diseases, including peripheral artery disease.
Introduction
Skeletal muscle damage following injury, disease, or unac-
customed exercise stimulates coordinated repair processes
from muscle and nonmuscle cell types, including cells
associated with the vasculature (Shi and Garry 2006; Hyl-
dahl et al. 2011; Boppart et al. 2013). Skeletal muscle is a
highly vascularized tissue with reports that there are as
many as 4–5 capillaries in contact with each muscle fiber
in the vastus lateralis of young healthy males (Groen et al.
2014). Capillaries and other microvascular vessels, includ-
ing precapillary arterioles and postcapillary venules, have
a single layer of endothelial cells on the luminal surface.
There is evidence that skeletal muscle-damaging exercise
affects these endothelial cells and causes microvascular
dysfunction (Kano et al. 2004, 2005). Additionally, peri-
cytes, which are cells found on the abluminal surface of
endothelial cells throughout the microvasculature, may
contribute to skeletal muscle repair (Dellavalle et al. 2011;
Hyldahl et al. 2011). The consequences of skeletal muscle
damage on the microvasculature, including angiogenic
processes or endothelial cell crosstalk with pericytes
remain unknown.
Pericytes are tissue-resident multipotent stem cells that
are ubiquitous throughout the microvasculature where
they reside under the basement membrane at a density
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ranging between 1:10 and 1:100 pericytes to endothelial
cells within skeletal muscle tissue (Tilton et al. 1979; She-
pro and Morel 1993; Hirschi and D’Amore 1996). They
are mesenchymal-like stem cells (Crisan et al. 2008) that
have the potential to differentiate down mesodermal lin-
eages toward adipogenic (Richardson et al. 1982), osteo-
genic (Diaz-Flores et al. 1992), and myogenic fates
(Dellavalle et al. 2011). Reports indicate that pericytes can
fuse with muscle fibers and contribute to the satellite cell
pool in vivo (Dellavalle et al. 2011). Additionally, peri-
cytes may contribute to skeletal muscle repair (Sassoli
et al. 2012) and cardiac muscle repair (Chen et al. 2013)
through paracrine effects, although the signaling mole-
cules remain largely unidentified. Previous work by Hyl-
dahl et al. (2011) has highlighted pericyte NF-jB activity
as a potential mechanism for pericyte involvement in
muscle repair. They showed that a muscle-damaging
eccentric exercise in humans caused NF-jB activation in
muscle-resident pericytes 3 h after exercise of the quadri-
ceps (Hyldahl et al. 2011). In a follow up in vitro study,
it was shown that pericyte NF-jB activation enhanced
skeletal myoblast proliferation and inhibited myoblast dif-
ferentiation (Hyldahl et al. 2013). The signals downstream
of NF-jB that mediate the cellular crosstalk between peri-
cytes and muscle cells have not been investigated.
Only a few studies have investigated the complex rela-
tionship between endothelial cells, pericytes, and skeletal
muscle following tissue damage. In a severe model of
muscle injury, Tamaki et al. (2005) showed that muscle-
derived mesenchymal stem cells (CD34+/CD45), which
are similar to pericytes in anatomical location, cell surface
marker expression, and function (Covas et al. 2008), con-
tributed to both vasculogenesis and myogenesis during
regeneration. Huntsman et al. (2013) reported that peri-
cytes contributed to arteriogenesis following 4 weeks of
eccentric exercise training in a transgenic animal model.
This same group investigated the potential paracrine sig-
naling factors secreted by pericytes in response to in vitro
mechanical strain. They identified epidermal growth fac-
tor (EGF), vascular endothelial growth factor (VEGF),
and interferon gamma-induced protein 10 (IP-10) as
potential mediators of the arteriogenic response (Hunts-
man et al. 2013). IP-10 is a target of NF-jB, which sup-
ports the hypothesis that NF-jB activation in pericytes
may be an important mediator of cellular crosstalk with
muscle and endothelial cells by regulating the transcrip-
tion of inflammatory cytokines. Another gene target of
NF-jB is monocyte chemoattractant protein-1 (MCP-1).
Evidence from both in vitro (Peterson and Pizza 2009)
and in vivo studies (Chen et al. 2003; Hyldahl et al.
2011) implicates MCP-1 as an important cytokine in
muscle repair, where its main role is the chemoattraction
of leukocytes, but may also have roles in angiogenesis and
regeneration (Yahiaoui et al. 2008; Lu et al. 2011). Other
proinflammatory cytokines known to be under the tran-
scriptional regulation of NF-jB, such as granulocyte mac-
rophage-colony stimulating factor (GM-CSF), may also
be secreted from pericytes with potential downstream
effects on endothelial cells (Huntsman et al. 2013).
Due to the close physical proximity between pericytes
and endothelial cells, as well as their interdependence for
maintaining microvascular homeostasis, we have hypothe-
sized that pericyte NF-jB activation following muscle
damage may also influence microvascular endothelial
cells. While evidence suggests that pericyte NF-jB activa-
tion following muscle damage may enhance myoblast
proliferation, little is known about the effects of pericyte
NF-jB activation on endothelial cell proliferation and
cell–cell signaling. Therefore, the purpose of this study
was to examine pericyte NF-jB activation in a model of
skeletal muscle damage; and use genetic manipulation to
study how pericyte NF-jB activation affects endothelial
cell proliferation and cytokine secretion.
Materials and Methods
Cell culture
Human primary pericytes isolated from placental tissue
were purchased from PromoCell (Heidelberg, Germany).
As reported by the supplier, the pericytes were positive
for the mesenchymal stem cell markers CD146 and
CD105 and negative for the endothelial cell markers
CD31 and CD34. Immunofluorescence experiments con-
firmed that the cells also expressed the pericyte marker
NG2 (data not shown). The cells displayed a stellate mor-
phology characteristic of pericytes (Bryan and D’Amore
2008). Pericytes between passages 6 and 9 were used for
experiments. Cultures were maintained at 37°C in a 5%
CO2 incubator in growth medium consisting of DMEM
supplemented with 10% FBS and 1% penicillin and strep-
tomycin. Cultures were passaged using 0.25% trypsin,
0.1% EDTA before reaching 80% confluence. C2C12 myo-
blasts were obtained from the American Type Culture
Collection (ATCC, Manassas, VA) and cultured under the
same conditions as the pericytes. To obtain myotube cul-
tures, C2C12 myoblasts were cultured in reduced growth
factor medium containing DMEM supplemented with 2%
horse serum and 1% penicillin and streptomycin for
4 days to induce differentiation into mature myotube cul-
tures. Human microvascular endothelial cells (HMVECs)
are an hTERT immortalized cell line (Shao and Guo
2004) that was cultured in endothelial basal medium-2
(EBM-2; Lonza, Walkersville, MD) supplemented with
10% FBS, 1% penicillin and streptomycin, 1 lg/mL EGF,
and 50 lg/mL hydrocortisone.
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Pericyte/C2C12 coculture
A transwell coculture system was used to facilitate
exchange of soluble factors while preventing the migra-
tion of cells between wells (0.4 lm pore size, Corning
Life Sciences, Tewksbury, MA). C2C12 myotube cultures
were grown in a 6-well plate format with pericytes
seeded in the transwell insert. Cocultures were main-
tained in a 5% CO2 incubator and culture medium was
replaced every 24 h at 4 days post myotube differentia-
tion, which coincided with ~80% pericyte confluency,
culture medium was replaced 3 h prior to the start of
the experiment to allow cells to equilibrate to fresh med-
ium. Next, myotube cultures were scratch-injured, which
created an open “wound” on the culture plate. To
impart the scratch-injury, a sterile gel-loading pipette tip
was used to generate a continuous and well-delineated
wound region along the surface of each plate producing
a total wound area equivalent to ~10% of the total sur-
face area of the C2C12 cell monolayer, similarly to the
methods previously described where scrape injury was
shown to cause myotube damage through lactate dehy-
drogenase release (Tsivitse et al. 2005). In parallel, con-
trol cocultures were established where no injury was
imparted to C2C12 cells. Three replicates were performed
for a baseline (BSLN), 3, 12, and 24 h time point for
uninjured control (CON) and injured (INJ) cultures. At
each time point, cell culture supernatant was collected
and immediately frozen at 80°C for subsequent analysis
of secreted MCP-1. Also at each time point, nuclear
extracts from pericytes and C2C12 cells, respectively, were
isolated via differential centrifugation using a cellular
extraction kit according to manufacturer’s instructions
(Nuclear Extract Kit; Active Motif, Carlsbad, CA) and
immediately frozen at 80°C.
ELISA-based NF-jB activation
Total nuclear protein content was determined using a
BSA-based protein quantification assay (ProStain; Active
Motif). An ELISA-based transcription factor assay kit
(TransAM NF-jB p65 Assay Kit; Active Motif) was used
to quantify NF-jB p65 subunit nuclear DNA binding
activity in pericytes and C2C12 cells from control and
injured cocultures according to manufacturer’s instruc-
tions. Briefly, 2 lg of nuclear protein was added to wells
coated with a consensus binding sequence for NF-jB
(50-GGGACTTTCC-30) and incubated for 1 h at room
temperature. Wild type and mutated consensus oligonu-
cleotides were used as competitors for NF-jB binding to
ensure specificity of the reaction as per manufacturer’s
instructions. Wells were then washed, and a primary
antibody directed at the p65 subunit was added and left
to incubate for 1 h. This was followed by treatment of
all wells with a secondary horseradish peroxidase-conju-
gated antibody. Then, developing solution was added to
initiate a colorimetric reaction. After 5 min, a stop solu-
tion was added and absorbance was measured at
450 nm on a multiwell microplate reader (FLUOstar
Optima; BMG Labtech, Offenburg, Germany). All sam-
ples were assayed in duplicate, and averages were used
for data analysis.
MCP-1 secretion
To determine MCP-1 secretion from human pericytes
and murine C2C12 cells, respective ELISAs for the detec-
tion of human (Human CCL2/MCP-1 Quantikine ELISA
kit; R&D Systems, Minneapolis, MN) and murine MCP-1
(Mouse /Rat CCL2/JE/MCP-1 Quantikine ELISA kit;
R&D Systems) were performed on cell culture superna-
tants. The kits were tested for species cross reactivity by
the manufacturer, and no cross reactivity was detected.
Assay kits employed the quantitative sandwich ELISA
technique, and were performed on undiluted samples
according to manufacturer’s instructions. A multiwell mi-
croplate reader was used (FLUOstar Optima; BMG Lab-
tech) to measure absorbance at 450 nm. Assays were
performed in duplicate and average values were used for
analysis.
Pericyte/HMVEC coculture
Pericytes were seeded in triplicate in a 6-well plate format
following transient transfection (described below) with
vectors designed to alter NF-jB activity. At 24 h after
transfection, medium was replaced with fresh medium
and coculture was initiated by seeding HMVECs onto
transwell inserts (0.4 lm pore size, Corning Life Sciences,
Tewksbury, MA). At 24 and 48 h after the initiation of
coculture, cell culture supernatants were collected and
immediately frozen at 80°C for analysis of cytokine
secretion. Endothelial cell number was quantified at 24
and 48 h (detailed below).
Transient transfections
Expression plasmids were used to alter NF-jB activation
in pericytes. A dominant negative (d.n.) IKKb (K44M)
was used to decrease NF-jB activation. It encodes a
kinase dead form of IKKb, and was developed in the lab-
oratory of Michael Karin, PhD (University of California,
San Diego, CA). A constitutively active (c.a.) IKKb (S177/
S188→EE) was used to increase NF-jB activation by
encoding for a constitutively active form of IKKb, and
was developed in the lab of Steven Shoelson, MD PhD
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 4 | e12309
Page 3
K. E. LaBarbera et al. Pericyte NF-jB Enhances Endothelial Cell Proliferation
(Joslin Diabetes Center, Boston, MA). For a control that
did not alter NF-jB activation, an empty vector of the
expression plasmid was used (pEF6/HisB; Invitrogen,
Carlsbad, CA). For visualization of the transfected pro-
teins, the d.n. IKKb and c.a. IKKb were subcloned into
the N-terminus of an EGFP expression vector (pEGFP-
n1; Clontech, Palo Alto, CA) by the laboratory of Susan
C Kandarian, PhD (Boston University, Boston, MA) to
create the d.n. IKKb-EGFP and c.a. IKKb-EGFP fusion
proteins. A Basic Nucleofector Kit for Primary Smooth
Muscle Cells (Lonza, Walkersville, MD) and a Nucleofec-
tor II machine (Amaxa, Gaithersburg, MD) using the P-
013 program was used to electroporate 5 lg of each
experimental plasmid plus 5 lg of the pNF-kB-MetLuc2-
Reporter plasmid (Clontech, Mountain View, CA) into
5 9 105 pericytes. Following electroporation of each
respective condition, pericytes were seeded in triplicate in
a 6-well plate.
Luciferase reporter assay
At 24 h post transfection, culture medium was collected
from each condition and assayed for luciferase using a
Ready-to-Glow Secreted Luciferase Reporter Assay (Clon-
tech, Mountain View, CA) according to manufacturer’s
instructions. The assay was run in triplicate and lumines-
cence was measured on a FLUOstar Optima plate reader
(BMG Labtech).
Endothelial cell number
At 24 and 48 h after coculture initiation, endothelial cells
were harvested from the transwell membrane using 0.25%
trypsin, 0.1% EDTA, and then cell number was quantified
using Trypan Blue staining and a hemocytometer. Two
cell counts were performed for each of the three replicates
per condition. Averages of the two counts were used for
statistical analysis.
Multiplex cytokine secretion assessment
Cell culture supernatant was collected from pericyte/
HMVEC cocultures at 24 h after coculture initiation. Cell
culture supernatant was also collected from pericyte
monocultures at the same time point. Supernatant was
centrifuged at 4°C for 10 min at 1500 rpm. Protein was
quantified using ProStain Protein Quantification kit
(Active Motif), and equal amounts of protein were
assayed for cytokine and chemokine concentration using
a Luminex Magpix multiplexing platform (Luminex Cor-
poration, Austin, TX). Quantification of cytokine/chemo-
kine concentrations in the culture supernatants was
carried out with a human cytokine/chemokine 42-plex
bead panel (Millipore Corporation, Billerica, MA). Muti-
plexing analysis was performed using reagents supplied by
Millipore according to the manufacturers recommenda-
tions. Briefly, antibody-conjugated magnetic beads were
incubated with cell culture supernatants (antigen) in a
96-well format followed by sequential incubations with
biotinylated detection antibody and streptavidin-phycoer-
ythrin. Bead complexes were then read on the Magpix
multiplex platform (Luminex Corporation). Sensitivity of
standards ranged between 3.2 and 10,000 pg/mL, giving a
broad range of sensitivity. Standard curves and data
analysis was performed using Milliplex Analyst 5.1 soft-
ware (Millipore Corporation).
Statistical analysis
A 3-way ANOVA was used to determine differences in
NF-jB activation for the main effects of cell type (peri-
cytes versus C2C12), time (BSLN, 3, 6, 24 h), and condi-
tion (control versus injured). Two-way ANOVA was used
to investigate differences in NF-jB activation of respective
cells types over time (BSLN, 3, 6, 24 h) and between con-
ditions (control versus injured). A 2-way ANOVA was
used to determine differences in endothelial cell prolifera-
tion between conditions (c.a. IKKb, d.n. IKKb, and e.v)
and over time (24 and 48 h). Multiplex cytokine data for
each individual cytokine of interest were tested for differ-
ences among conditions using a 1-way ANOVA. Signifi-
cant main effects and interactions were investigated using
t-tests or Tukey’s honest significant difference post hoc
test where appropriate. Significance was set a priori at
P < 0.05.
Results
NF-jB activation in an in vitro pericyte/C2C12
coculture model of muscle injury
Pericytes were cocultured with C2C12 myotubes using
transwell inserts to examine the time course of pericyte
and muscle cell NF-jB activation. In this coculture
model, the C2C12 p65 DNA binding activity was signifi-
cantly elevated at 3 h (2.5-fold, P = 0.027) and 24 h
(3.57-fold, P = 0.001) relative to BSLN. There was no dif-
ference in C2C12 p65 DNA binding activity in INJ com-
pared to CON (P = 0.698). In the same cocultures,
pericyte p65 DNA binding activity was increased relative
to BSLN at 6 h (2.0-fold, P = 0.007), and 24 h (2.33-fold,
P = 0.001). Pericytes trended toward greater p65 DNA
binding activity in INJ compared to CON (P = 0.085).
Further, pericytes trended toward greater overall p65
DNA binding activity compared to C2C12 cells
(P = 0.079) (Fig. 1).
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MCP-1 is secreted by pericytes in pericyte/
C2C12 coculture model of muscle injury
The pericyte and muscle cell coculture model was utilized
to investigate secreted signaling molecules involved in
pericyte-muscle cell crosstalk. In the coculture model,
pericyte MCP-1 secretion was first detected 24 h post
injury, and it exceeded C2C12 MCP-1 secretion (2.1-fold,
P < 0.001) at this time point in INJ and CON conditions.
C2C12 MCP-1 secretion was increased compared to BSLN
at 6 h (1.6-fold, P = 0.032) and 24 h post injury (3.0-
fold, P < 0.001). There were no differences in MCP-1
secretion between INJ and CON for pericytes or C2C12
cells (Fig. 2).
Pericyte NF-jB genetic manipulation
To investigate the downstream effects of pericyte NF-jB
activation, an in vitro coculture model was developed that
utilized pericytes with genetically altered NF-jB activa-
tion. Pericytes were genetically altered via transfection
with expression plasmids designed to enhance (c.a. IKKb-
EGFP), reduce (d.n. IKKb-EGFP), or have no impact
(e.v. EGFP) on NF-jB activity. The transfection efficiency
was approximately 65–75% based on the percentage of
EGFP fluorescent pericytes at 24 h after transfection
(Fig. 3A). Transfection efficiency was not different
between conditions. The transfection efficacy was assessed
using a luciferase assay (Fig. 3B). At 24 h post transfec-
tion, luciferase activity was increased 6.1-fold in the c.a.
IKKb condition compared to the e.v. control condition.
The luciferase activity in the d.n. IKKb was decreased
10% compared to e.v. control condition.
Pericyte NF-jB activation enhances HMVEC
proliferation in coculture
Genetically altered pericytes were cocultured with
HMVECs using transwell inserts to investigate the effects
of altered pericyte NF-jB activation on endothelial cell
proliferation. In pericyte/HMVEC cocultures, there was
an increase in HMVEC cell number, a measure of prolif-
eration, from 24 to 48 h for all conditions (P = 0.002,
1.3-fold). HMVEC proliferation was significantly greater
in the c.a. IKKb pericyte coculture condition compared
to the d.n. IKKb pericyte coculture condition (P = 0.002,
1.3-fold; Fig. 4).
Cytokine secretion from pericyte
monocultures and pericyte/HMVEC
cocultures
To assess signaling molecules that may mediate the prolif-
erative response in endothelial cells, cell culture superna-
tant was assayed for cytokine concentration. Cell culture
supernatants were collected in pericyte/HMVEC cocul-
tures at 24 h after the initiation of coculture and at the
corresponding time point in pericyte monocultures.
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Figure 1. Time course of NF-jB activation in cocultured C2C12 cells
and pericytes. p65 DNA binding activity for cocultured C2C12 cells
and pericytes in uninjured control (CON) and scratch-injured (INJ)
conditions at baseline (BSLN), 3, 6, and 24 h time points. Data are
means  SD. *Significantly increased compared to BSLN for C2C12
cells. †Significantly increased compared to BSLN for pericytes.
0 
20 
40 
60 
80 
100 
120 
140 
160 
180 
BSLN 3 h 6 h 24 h 
M
C
P-
1 
Se
cr
et
io
n 
(p
g/
m
L
) 
Time post-injury 
C2C12 CON 
C2C12 INJ 
PERICYTE CON 
PERICYTE INJ 
* 
* 
Figure 2. Time course of MCP-1 secretion from cocultured
pericytes and C2C12 cells. Monocyte chemoattractant protein-1
(MCP-1) secretion by cocultured C2C12 cells and pericytes in
uninjured control (CON) and scratch-injured (INJ) conditions at
baseline (BSLN), 3, 6, and 24 h time points. Data are means  SD.
*Significantly increased compared to BSLN for C2C12 cells.
†Significantly greater vs. C2C12 cells at 24 h.
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The following cytokines were secreted from pericytes in
monoculture in the c.a. IKKb condition, but were not
detected in the d.n. IKKb condition or e.v. control condi-
tion: eotaxin (15.61  2.7 qg/mL), granulocyte colony-
stimulating factor (G-CSF, 17.21  4.6 qg/mL), GM-CSF
(15.16  4.6 qg/mL), fractalkine (CX3CL1, 30.87  5.3
qg/mL), interferon alpha-2 (IFNA2, 8.62  1.6 qg/mL),
growth-regulated oncogene (GRO, 8.41  6.0 qg/mL),
interleukin 6 (IL-6, 45.52  9.7 qg/mL), interleukin 7
(IL-7, 11.27  2.0 qg/mL), IP-10 (196.56  91.3 qg/mL),
and macrophage inflammatory protein-1 alpha (MIP-1a,
38.57  10.9 qg/mL). There was greater cytokine secre-
tion in the c.a. IKKb condition compared to both d.n.
IKKb (P < 0.01) and e.v. conditions (P < 0.01), respec-
tively, for the following cytokines: interleukin 8 (IL-8,
599.16  192.5 vs. 1.70  0.9 and 3.54  1.1 qg/mL),
MCP-1 (32.56  9.3 vs. 4.14  1.7 and 5.00  2.6 qg/
mL), and regulated on activation, normal T-cell expressed
and secreted (RANTES, 209.18  73.3 vs. 4.24  2.0 and
5.96  3.1 qg/mL).
In cocultures, there was greater cytokine secretion in the
c.a. IKKb condition compared to both d.n. IKKb (P < 0.05)
and e.v. conditions (P < 0.05), respectively, for the follow-
ing cytokines: eotaxin (16.16  0.6 vs. 3.32  4.7 and
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Figure 3. Pericyte transfection efficacy and efficiency in altering NF-jB activation. (A) Representative images of pericytes transfected with
vectors designed to enhance (constitutively active (c.a.) IKKb-EGFP), diminish (dominant negative (d.n.) IKKb-EGFP), or have no effect on (empty
vector (e.v.) pEF6/HisB) NF-jB activity at 24 h post transfection. (B) A luciferase reporter system was used to assess the ability of expression
plasmids to alter NF-jB expression. Data are means  SD.
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7.26  1.3 qg/mL), G-CSF (55.81  11.6 vs. 10.27  5.4
and 22.13  4.8 qg/mL), RANTES (253.62  61.7 vs.
9.23  5.8 and 23.95  5.3 qg/mL), fractalkine (30.07  3.1
vs. 3.91  5.5 and 7.22  5.8 qg/mL), IL-6 (45.27  9.7 vs.
5.88  5.3 and 14.80  4.2 qg/mL), IL-7 (12.26  1.8
vs. 1.18  1.7 and 1.58  2.2 qg/mL), IL-8 (707.73  205.4
vs. 59.94  30.8 and 110.29  20.0 qg/mL),MCP-1 (28.01 
7.3 vs. 2.38  1.4 and 6.31  1.1 qg/mL), and IP-10
(146.15  45.1 vs. 2.38  3.4 and 7.53  10.6 qg/mL)
(Fig. 5). IFNA2 (8.15  2.6 qg/mL), GM-CSF (10.19 
3.1 qg/mL), and MIP-1a (18.74  4.7 qg/mL) were only
detected in the c.a. IKKb condition.
Discussion
Skeletal muscle resident pericytes have known roles in
muscle repair and regeneration. Previous work in our lab-
oratory demonstrated that pericytes activate NF-jB in
response to muscle damage in humans. In support of pre-
vious work, our first main finding provides further in vi-
tro evidence for pericytes as a source of NF-jB activation
following muscle damage. Second, through genetic
manipulation, we showed that NF-jB activation in peri-
cytes enhanced the proliferation of cocultured endothelial
cells. Finally, we identified several paracrine-signaling
molecules that may mediate the crosstalk between peri-
cytes and endothelial cells.
Pericytes activate NF-jB in response to
muscle damage
Previous studies have documented the importance of
NF-jB activation in skeletal muscle tissue for the regula-
tion of myogenesis (Guttridge et al. 1999, 2000; Peterson
et al. 2011) as well as in muscle injury (Mourkioti et al.
2006) and disease (Cai et al. 2004). Hyldahl et al. (2011)
demonstrated pericyte NF-jB activation in muscle injury
and regeneration in humans. In this study, we provide
further evidence for pericytes as a source of NF-jB activa-
tion. Our in vitro model of acute muscle injury allowed
us to quantify nuclear NF-jB binding activity and sug-
gests that pericytes may potentially activate NF-jB to a
greater extent than muscle cells, although only a trend for
increased pericyte NF-jB activation was achieved in this
study. Nevertheless, the data support our hypothesis that
pericytes are key mediators of the inflammatory response
during skeletal muscle regeneration. This model also
allowed us to examine the crosstalk mechanisms that pro-
mote NF-jB activation in pericytes.
At early time points following scratch-injury to muscle
cells, MCP-1 was secreted by muscle cells, although no
statistical difference between scratch-injured and control
cultures was detected. Other studies have observed
increased cytokine secretion from C2C12 cells using vari-
ous models of muscle stress. Peterson and Pizza (2009)
showed that C2C12 cells secreted MCP-1 in response to in
vitro mechanical strain. Using an in vitro exercise model,
Scheler et al. (2013) observed gene enrichment of NF-jB
related genes, including the CCL2 gene that encodes the
MCP-1 protein, as well as CCL5 and CXCL1 genes, which
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Figure 4. HMVEC proliferation is affected by pericyte NF-jB
activation in coculture. Human microvascular endothelial cell
(HMVEC) number in coculture with pericytes expressing
constitutively active IKKb (c.a.), dominant negative IKKb (d.n.), or
empty vector control (e.v.). Data are means  SD. *Significant
difference between c.a. and d.n.
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Figure 5. Pericyte NF-jB activation affects cytokine secretion in
pericyte/HMVEC cocultures. Cytokine secretion of granulocyte-
colony stimulating factor (G-CSF), fractalkine, interleukin 6 (IL-6),
interleukin 7 (IL-7), interleukin 8 (IL-8), interferon gamma-induced
protein-10 (IP-10), monocyte chemoattractant protein-1 (MCP-1),
regulated on activation, normal T-cell expressed and secreted
(RANTES), and eotaxin in the cocultures of human microvascular
endothelial cells (HMVECs) and pericytes that were genetically
altered to express constitutively active IKKb (c.a.) or dominant
negative IKKb (d.n.) in comparison to empty vector control (e.v.).
Significantly greater cytokine concentration was observed in the
c.a. IKKb condition compared to both e.v. and d.n. IKKb conditions
for all cytokines (P < 0.05).
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encode RANTES and growth regulated oncogene (GRO)
proteins, respectively. They also showed increased secre-
tion of the MCP-1 protein (Scheler et al. 2013). In a
human study, Catoire et al. (2014) found increased gene
expression and protein secretion of MCP-1 in muscle
biopsies and plasma, respectively, again highlighting the
role of this cytokine in the muscle tissue response to
stress; however, the cellular sources of MCP-1 were not
determined in that study. In this study, we utilized a co-
culture with pericytes, and our finding of no change in
MCP-1 secretion in response to acute injury, which is in
contrast to previous studies, may indicate that pericytes
modulated the inflammatory response in muscle cells,
and thereby attenuated significant MCP-1 secretion from
muscle cells. In the current study, we also showed that
pericytes could secrete MCP-1, and further, that they may
secrete greater quantities of MCP-1 than muscle cells.
This provides further evidence that pericytes are impor-
tant components of muscle cell crosstalk. Still, other
cytokines should be investigated using this model to fully
understand the cell crosstalk between pericytes and
muscle cells.
Pericyte NF-jB activation enhances
endothelial cell proliferation
The downstream effects of NF-jB activation on cells in
the muscle tissue environment are mostly unknown. Due
to the close physical proximity between pericytes and
endothelial cells, as well as the importance of a healthy
microvasculature to promote muscle repair, we investi-
gated the effects of pericyte NF-jB activation on endo-
thelial cells. We showed that NF-jB activation in
pericytes enhanced endothelial cell proliferation. Endothe-
lial cell proliferation is one component of angiogenesis,
indicating that pericyte NF-jB activation may be impor-
tant for the promotion of angiogenesis. Hyldahl et al.
(2013) demonstrated that increased pericyte NF-jB acti-
vation enhanced myoblast proliferation in coculture while
also inhibiting pericyte differentiation into myotubes.
These two studies show that acute NF-jB activation can
enhance cellular proliferation in skeletal muscle tissue.
This is in contrast to studies showing that chronic NF-jB
activation in disease can lead to cachexia or muscle wast-
ing (Cai et al. 2004), and thus demonstrates the paradox-
ical effects of inflammation. While acute inflammation
may be necessary for tissue repair and vascular remodel-
ing (Silvestre et al. 2008), chronic inflammation has neg-
ative effects (Khatami 2011). Importantly, if pericytes are
mediators of the inflammatory response, this highlights
the importance of a healthy pericyte population that can
respond to damage and execute appropriate inflammatory
signaling.
Pericyte NF-jB activation enhances
inflammatory and angiogenic crosstalk
In order to elucidate cytokines that may be involved in
the paracrine signaling that mediates the proliferative
response in endothelial cells, we used an unbiased tech-
nique to screen the conditioned media of endothelial cell/
pericyte cocultures and pericyte monocultures. Using this
approach, we saw differential concentrations of several
cytokines in the various NF-jB activation conditions. All
these cytokines are known gene targets of NF-jB; and
therefore, further supports the efficacy of our transfection.
The cytokines that were present in the highest concentra-
tion in our cultures were IL-8, IP-10, and RANTES, and
with the addition of IL-7, this group of cytokines also
had the greatest fold change in the enhanced NF-jB acti-
vation condition compared to the control condition. IL-8
is a proangiogenic cytokine in the CXC family, and it sig-
nals through the CXCR2 receptor to directly affect angio-
genesis (Koch et al. 1992; Strieter et al. 1995). In a model
of thyroid cancer, Bauerle and colleagues (Bauerle et al.
2014) showed that NF-jB regulated the expression of IL-
8, which enhanced tumor cell growth in vivo and endo-
thelial cell tube formation in vitro. IP-10 is another mem-
ber of the CXC family of cytokines, but contrary to IL-8,
it is angiostatic and signals through the CXCR3 receptor
(Romagnani et al. 2001; Mehrad et al. 2007). In addition
to the concentration of signaling molecules, receptor con-
centration on endothelial cells are also important in the
balance between angiogenesis and angiostasis. Although
our study was not designed to investigate receptor den-
sity, it is possible that there are more CXCR2 receptors
than CXCR3 receptors on our HMVECs. Furthermore,
some levels of angiostatic cytokines are likely necessary to
balance angiogenic signals and prevent uncontrolled cell
growth.
MCP-1 and RANTES, members of the CC cytokine
family, were also increased in the coculture condition of
HMVECs and pericytes with enhanced NF-jB activation.
Many cell types may secrete MCP-1 following damage,
and this study shows that pericytes secrete MCP-1 follow-
ing NF-jB activation. MCP-1 is mainly known for its role
in leukocyte chemoattraction; however, previous studies
have also shown a role for MCP-1 in angiogenesis (Salce-
do et al. 2000; Ma et al. 2007). Ma et al. (2007) showed
that MCP-1 mediated angiogenesis through the recruit-
ment of mural cells, which provides a link between
inflammatory signaling molecules and angiogenesis. The
role of RANTES in angiogenesis is more controversial
(Suffee et al. 2011). It can signal through multiple surface
receptors where some studies have observed a proangio-
genic effect (Westerweel et al. 2008) and others have
demonstrated antiangiogenic effects (Barcelos et al. 2009).
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Importantly, the candidate cytokines that were identified
in this study as NF-jB driven mediators of pericyte-endo-
thelial cell crosstalk are known inflammatory signaling
molecules. Therefore, this study provides evidence for the
link between inflammation and angiogenesis.
Limitations
There are several recognized limitations to this study.
First, we did not directly quantify muscle damage from
our in vitro scrape injury model. Next, we did not extend
our time series to 48 h in our pericyte/C2C12 cocultures,
which may have revealed significant differences in pericyte
NF-jB activation between injured and control conditions.
Another limitation of this study is a lack of a secondary
measure of endothelial cell proliferation. The impact of
the endothelial cell proliferation results is limited by a
lack of a statistically significant difference between endo-
thelial cell numbers in the control condition compared to
either increased or decreased NF-jB activation condi-
tions. Future studies should follow up on the candidate
cytokines identified in this study to identify which cyto-
kines promote proliferation. Finally, these findings would
be strengthened by validation in an in vivo model and
investigation into the reciprocal effects of endothelial cells
on pericytes.
Conclusions
Skeletal muscle is a complex tissue with a high regenera-
tive capacity. However, debilitating diseases and injuries
affect skeletal muscle function and regeneration. In order
to target and optimize therapies, the cellular and molecu-
lar mechanisms of muscle regeneration must be under-
stood, including the crosstalk between different cell types.
We have provided further evidence that pericyte NF-jB
activation may be an important component of the skeletal
muscle inflammatory response to injury. We have also
shown that pericyte NF-jB activation can influence endo-
thelial cell proliferation, which occurs through paracrine
signaling with the candidate inflammatory cytokines that
were identified in our screen. As components of the
microvasculature, pericytes and endothelial cells are essen-
tial elements of a healthy skeletal muscle tissue; and
therefore, this study may also have implications for mus-
culoskeletal diseases as well as vascular diseases, including
peripheral artery disease.
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